AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Nasal Polyps Treatment Market: Industry Analysis, Size, Share, Growth, Trends & Forecast, 2019-2027 - ResearchAndMarkets.com

January 3, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 3, 2020--

The “Nasal Polyps Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027” report has been added to ResearchAndMarkets.com’s offering.

A new study on the global nasal polyps treatment market presents a wealth of information on the key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the nasal polyps treatment market. This study offers valuable information about the nasal polyps treatment market, to illustrate how growth will discern during the forecast period of 2019-2027.

Key indicators of market growth, which include value chain as well as supply chain analysis, and Compound Annual Growth Rate (CAGR), are elucidated in This study in a comprehensive manner. This data can help readers interpret the quantitative growth aspects of the nasal polyps treatment market during the forecast period.

An extensive analysis on leading market players’ business strategies is also featured in This study on the nasal polyps treatment market. This can help readers understand principal factors to foresee growth in the nasal polyps treatment market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the nasal polyps treatment market, which will guide market players in making apt decisions in the future.

Key Questions Answered in the Nasal Polyps Treatment Market Study

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nasal Polyps Treatment Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.4. Global Nasal Polyps Treatment Market Analysis and Forecast, 2017-2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Key Industry Developments

5.2. Pipeline Analysis

5.3. Qualitative Assessment on Novel Treatment Options for Nasal Polyps: Biologics & Stents

5.3.1. Key Insights on Biologics (Xolair, Dupixent, Nucala)

6. Global Nasal Polyps Treatment Market Analysis and Forecast, by Type of Treatment

6.1. Introduction & Definition

6.2. Market Value Forecast, by Type of Treatment , 2017-2027

6.3. Market Attractiveness By Type of Treatment

7. Global Nasal Polyps Treatment Market Analysis and Forecast, by End-user

7.1. Introduction & Definition

7.2. Market Value Forecast, by End-user, 2017-2027

7.3. Market Attractiveness, by End-user

8. Global Nasal Polyps Treatment Market Analysis and Forecast, by Region

8.1. Introduction

8.2. Market Value Forecast, by Region

8.3. Market Attractiveness, by Country/Region

9. North America Nasal Polyps Treatment Market Analysis and Forecast

9.1. Introduction

9.2. Market Value Forecast, by Type of Treatment , 2017-2027

9.3. Market Value Forecast, by End-user, 2017-2027

9.4. Market Value Forecast, by Country, 2017-2027

9.5. Market Attractiveness Analysis

10. Europe Nasal Polyps Treatment Market Analysis and Forecast

11. Asia Pacific Nasal Polyps Treatment Market Analysis and Forecast

12. Latin America Nasal Polyps Treatment Market Analysis and Forecast

13. Middle East & Africa Nasal Polyps Treatment Market Analysis and Forecast

14. Competition Landscape

14.1. Market Player - Competition Matrix (By Tier and Size of companies)

14.2. Global Nasal Polyps Treatment Market Position Analysis, by Company, 2018

14.3. Company Profiles

14.3.1. OptiNose US, Inc.

14.3.2. Regeneron Pharmaceuticals, Inc.

14.3.3. Merck & Co., Inc.

14.3.4. Pfizer, Inc.

14.3.5. F. Hoffmann La-Roche, Ltd.

14.3.6. Intersect ENT, Inc.

14.3.7. GlaxoSmithKline plc

14.3.8. Sanofi

14.3.9. Novartis AG

For more information about this report visit https://www.researchandmarkets.com/r/3cyfks

View source version on businesswire.com:https://www.businesswire.com/news/home/20200103005134/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/03/2020 06:10 AM/DISC: 01/03/2020 06:10 AM

http://www.businesswire.com/news/home/20200103005134/en